Rasopathy Disorders

Rasopathy Disorders News

• NIH programs shed light on gene variants and their connections to health and disease 12 Oct 2018 16:40 Medical Xpress Programs supported by the National Institutes of Health are establishing which genes and genomic variants play a role in human disease, enabling their use in genomic medicine and research. NIH's Clinical Genome Resource (ClinGen) and ClinVar programs …
• The perils of living with neurofibromatosis 22 Aug 2018 10:42 Voice A pensioner with a rare skin condition, neurofibromatosis, wants his bulging right buttock to be surgically removed. For much of his life, 68-year-old Ntlhogo Serinane has suffered in dignified, resigned silence from the disease, which causes his skin to …
• Onconova Therapeutics, Inc. (ONTX) CEO Ramesh Kumar on Q2 2018 Results - Earnings Call Transcript 14 Aug 2018 16:51 Seeking Alpha Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q2 2018 Earnings Conference Call August 14, 2018 9:00 AM ET Executives Ramesh Kumar - President and Chief Executive Officer Steven Fruchtman - President and Chief Medical Officer Mark Guerin - Chief Financial …
• Onconova Therapeutics' (ONTX) CEO Ramesh Kumar on Q4 2017 Results - Earnings Call Transcript 09 Mar 2018 01:19 Seeking Alpha Start Time: 09:00 January 1, 0000 9:30 AM ET Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q4 2017 Earnings Conference Call March 08, 2018, 09:00 AM ET Executives Ramesh Kumar - CEO Mark Guerin - CFO Analysts Joe Pantginis - H.C. Wainwright Yale Jen - Laidlaw …
• International symposium on developments in neurofibromatoses, rasopathies to be held at Kochi from Nov 27─29 25 Nov 2017 06:22 Pharmabiz.com An international symposium on new developments in neurofibromatoses and rasopathies will be held from 27th  to 29th November 2017 at Crowne Plaza, Kochi (Cochin), Kerala, South India, which will deliberate on their management, diagnosis, current and …
• Onconova Therapeutics' (ONTX) CEO Ramesh Kumar on Q3 2017 Results - Earnings Call Transcript 09 Nov 2017 22:08 Seeking Alpha Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q3 2017 Earnings Conference Call November 9, 2017 09:00 AM EST Executives Ramesh Kumar - CEO Mark Guerin - CFO Analysts Jason McCarthy - Maxim Group Joe Pantginis - H.C. Wainwright Operator Good morning, and …
• Your Daily Pharma Scoop: MannKind Is A Trade Not An Investment; AstraZeneca's Imfinzi 10 Oct 2017 16:55 Seeking Alpha This abridged "Daily Scoop" is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of Top Seeking Alpha Coverage: MannKind …
• BioNJ's Patient Advocacy Summit: Educate. Engage. Empower. 06 Sep 2017 19:35 PharmiWeb.com BioNJ Posted on: 06 Sep 17 BioNJ's 2nd Annual Patient Advocacy Summit is slated for Wednesday, November 8, at Celgene Corporation, Summit, NJ. The full-day event will bring together New Jersey's patient advocacy community with industry and …
• Benefit Planned For Acadiana Girl Battling Genetic Condition 31 May 2017 21:47 KPEL Subscribe to News Talk 96.5 KPEL on We have a ton of people come in and out of the KPEL studio doors, but this little girl was different. Little Amelie is battling CFC or Cardiofaciocutaneous. It took several doctors 11 months to figure out why little …
• Onconova Therapeutics' (ONTX) CEO Ramesh Kumar on Q1 2017 Results - Earnings Call Transcript 15 May 2017 20:20 Seeking Alpha Onconova Therapeutics (NASDAQ:ONTX) Q1 2017 Earnings Conference Call May 15, 2017 09:00 a.m. ET Executives Ramesh Kumar - CEO Mark Guerin - CFO Lisa Sher - IR Analysts Jason McCarthy - Maxim Group Yale Jen - Laidlaw & Company Kumaraguru Raja - Noble …